Logo
x

Search

Subscribe Now

EMA

Unlocking Approval: Jacqueline Nielsen from AbbVie & Tahi Ahmadi from Genmab in a Riveting Conversation with PharmaShots

Unlocking Approval: Jacqueline Nielsen from AbbVie & Tahi Ahmadi from Genmab in a Riveting Conversation with PharmaShots

  • September 18, 2024
Insights+: EMA Marketing Authorization of New Drugs in June 2024

Insights+: EMA Marketing Authorization of New Drugs in June 2024

  • July 23, 2024
Moderna’s mResvia (mRNA-1345) Gains the CHMP’s Positive Opinion to Prevent Lower Respiratory Tract Disease (LTRD)

Moderna’s mResvia (mRNA-1345) Gains the CHMP’s Positive Opinion to Prevent Lower Respiratory Tract Disease (LTRD)

  • June 27, 2024
EMA Adopts Positive Opinion for Bekemv (biosimilar, eculizumab) to Treat Paroxysmal Nocturnal Haemoglobinuria

EMA Adopts Positive Opinion for Bekemv (biosimilar, eculizumab) to Treat Paroxysmal Nocturnal Haemoglobinuria

  • February 23, 2023
The EMA and HMA Acquired Big Data Strategy to Folster Veterinary Therapies in the EU

The EMA and HMA Acquired Big Data Strategy to Folster Veterinary Therapies in the EU

  • June 15, 2022
The EMA Rejects Prestige BioPharma’s Tuznue and Hervelous, a proposed biosimilars of trastuzumab for HER2-Positive Breast and Gastric Cancers

The EMA Rejects Prestige BioPharma’s Tuznue and Hervelous, a proposed biosimilars of trastuzumab for HER2-Positive Breast and Gast...

  • May 20, 2022
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.